End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
6.77
CNY
|
+1.96%
|
|
+1.80%
|
-30.85%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
10,604
|
3,529
|
2,973
|
3,400
|
6,203
|
4,056
|
Enterprise Value (EV)
1 |
10,377
|
3,869
|
3,111
|
3,417
|
5,996
|
4,183
|
P/E ratio
|
121
x
|
50.3
x
|
72.6
x
|
58.1
x
|
30.3
x
|
46.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.21
x
|
1.02
x
|
0.89
x
|
0.54
x
|
0.91
x
|
0.66
x
|
EV / Revenue
|
3.14
x
|
1.12
x
|
0.93
x
|
0.55
x
|
0.88
x
|
0.68
x
|
EV / EBITDA
|
82.9
x
|
30.8
x
|
20.7
x
|
33.3
x
|
35.1
x
|
35.6
x
|
EV / FCF
|
-307
x
|
-14.2
x
|
18.5
x
|
-17.4
x
|
73.7
x
|
-13.2
x
|
FCF Yield
|
-0.33%
|
-7.02%
|
5.41%
|
-5.75%
|
1.36%
|
-7.6%
|
Price to Book
|
6.25
x
|
2
x
|
1.53
x
|
1.69
x
|
2.77
x
|
1.76
x
|
Nbr of stocks (in thousands)
|
585,216
|
585,216
|
585,216
|
585,216
|
585,216
|
585,216
|
Reference price
2 |
18.12
|
6.030
|
5.080
|
5.810
|
10.60
|
6.930
|
Announcement Date
|
3/22/18
|
4/28/19
|
6/14/20
|
4/28/21
|
4/21/22
|
4/28/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
3,305
|
3,445
|
3,338
|
6,243
|
6,838
|
6,165
|
EBITDA
1 |
125.2
|
125.6
|
150.5
|
102.6
|
170.7
|
117.5
|
EBIT
1 |
91.85
|
91.32
|
116.3
|
75.04
|
142.9
|
83.18
|
Operating Margin
|
2.78%
|
2.65%
|
3.49%
|
1.2%
|
2.09%
|
1.35%
|
Earnings before Tax (EBT)
1 |
97.34
|
71.31
|
46.2
|
81.25
|
227.3
|
91.11
|
Net income
1 |
89.85
|
73
|
38.53
|
56.87
|
203.9
|
88.05
|
Net margin
|
2.72%
|
2.12%
|
1.15%
|
0.91%
|
2.98%
|
1.43%
|
EPS
2 |
0.1500
|
0.1200
|
0.0700
|
0.1000
|
0.3500
|
0.1500
|
Free Cash Flow
1 |
-33.75
|
-271.8
|
168.5
|
-196.4
|
81.32
|
-318
|
FCF margin
|
-1.02%
|
-7.89%
|
5.05%
|
-3.15%
|
1.19%
|
-5.16%
|
FCF Conversion (EBITDA)
|
-
|
-
|
111.94%
|
-
|
47.65%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
437.24%
|
-
|
39.89%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/22/18
|
4/28/19
|
6/14/20
|
4/28/21
|
4/21/22
|
4/28/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
340
|
138
|
17.1
|
-
|
127
|
Net Cash position
1 |
227
|
-
|
-
|
-
|
207
|
-
|
Leverage (Debt/EBITDA)
|
-
|
2.711
x
|
0.9184
x
|
0.1667
x
|
-
|
1.081
x
|
Free Cash Flow
1 |
-33.8
|
-272
|
168
|
-196
|
81.3
|
-318
|
ROE (net income / shareholders' equity)
|
4.67%
|
3.71%
|
1.82%
|
3.12%
|
9.88%
|
3.19%
|
ROA (Net income/ Total Assets)
|
2.36%
|
1.9%
|
1.88%
|
1.08%
|
1.95%
|
1.06%
|
Assets
1 |
3,800
|
3,832
|
2,051
|
5,247
|
10,440
|
8,289
|
Book Value Per Share
2 |
2.900
|
3.010
|
3.320
|
3.450
|
3.830
|
3.950
|
Cash Flow per Share
2 |
0.7000
|
1.390
|
2.080
|
1.240
|
1.320
|
1.180
|
Capex
1 |
36.3
|
16
|
9.81
|
38.2
|
56.7
|
324
|
Capex / Sales
|
1.1%
|
0.46%
|
0.29%
|
0.61%
|
0.83%
|
5.25%
|
Announcement Date
|
3/22/18
|
4/28/19
|
6/14/20
|
4/28/21
|
4/21/22
|
4/28/23
|
|
1st Jan change
|
Capi.
|
---|
| -30.85% | 547M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|